Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cisco Systems Inc (CSCO) vs Moderna, Inc. (MRNA) Price & Performance

Cisco Systems IncTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Cisco Systems Inc vs Moderna, Inc. — how do they compare? Cisco Systems Inc trades at $122.14 (market cap $474.67B), while Moderna, Inc. trades at $60.77 (market cap $24.18B). The key difference: Cisco Systems Inc is far larger — about 19.6× Moderna, Inc.'s market cap, and Cisco Systems Inc pays a 1.4% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

CSCOMRNA
Market Cap
$474.67B$24.18B
Volume
22,887,319
Sector
TechnologyHealth
52-Week High
$130.00$81.80
52-Week Low
$66.20$22.36
Enterprise Value
$489.33B$20.33B
Dividend Yield
1.4%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cisco Systems Inc

Cisco Systems (CSCO) trades at $120.43, down 0.82% on the day, amid a bullish technical outlook and strong earnings beats. The stock shows robust fundamentals with a 64.33% gross margin and consistent quarterly EPS outperformance. Recent AI cybersecurity initiatives and partner expansions fuel positive sentiment, with a consensus price target of $133.25 implying upside potential.

The outlook remains favorable given AI-driven growth catalysts and solid cash flow, though elevated valuation ratios and competitive pressures pose risks. Analyst consensus leans bullish with 52% buy ratings, supporting a constructive view for investors seeking exposure to networking and cybersecurity trends.

Moderna, Inc.

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cisco Systems Inc

Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.

Read more on CSCO

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA